All updated as on -
In 2021, the size of the biotechnology market was estimated at USD 44.10 billion. From 2022 to 2030, the market will increase at a CAGR of 6.7%. Key competitors in the industry are actively promoting their goods to stay competitive and draw in customers from around the world.
The market for biotechnology, which was estimated to be worth USD 44.1 billion in 2021, is anticipated to expand at a CAGR OF 6.7% from 2022 to 2030. Japan, one of the world's biggest biotechnology marketplaces, gives research and development a high emphasis. Through a number of programmes, including tax exemptions and funding for R&D, the Japanese government has actively promoted the expansion of the biotechnology sector. The nation's sophisticated healthcare system and the increased need for better drugs brought on by the high proportion of senior residents there further support the growth of the biotechnology sector globally.
This study classifies the Japan Biotechnology Market into a number of regions and market segments, projects revenue growth, and examines trends in each submarket. The main growth factors, opportunities, and difficulties affecting the Japan Biotechnology Market are analysed in the report. The competitive landscape in the market has been depicted by including recent market developments and competitive tactics including growth, product launch and development, partnerships, mergers, and acquisitions. The key market players are strategically identified, profiled, and their core competencies in each of the Japan Biotechnology Market's sub-segments are analysed in the study.
Driving Factors
The Japanese biotechnology market is expanding as a result of a number of factors, including the huge geriatric population (25 percent of the country's population is over 65 years old). As a result, there is now a greater need for healthcare services and cutting-edge anti-aging drugs. Recent increases in healthcare spending by the Japanese government have led to more funding for research and development in the biotechnology sector, which is another key factor in Japan's economic expansion. Additionally, the biotechnology industry has benefited from Japan's standing as a leader in technological innovation. The Japanese government has aggressively supported the expansion of the biotechnology sector through a number of initiatives, such as tax breaks and financing for R&D. With regard to research and development, Japan has a stellar track record thanks to superior research capabilities, particularly in industries like pharmaceuticals and medical devices. This has given the biotechnology sector a plethora of information and experience. Throughout the projection period, it is anticipated that these driving forces will continue to support the expansion of the Japanese biotechnology market.
Restraining Factors
The Japan Biotechnology Market is experiencing growth restraints as a result of regulatory issues. The biotechnology sector in Japan is highly regulated, which can make it challenging for businesses to launch new products. The regulatory process can be prohibitively expensive and time-consuming for smaller enterprises. Additionally, there are numerous well-established players in the market, which makes it quite competitive. This may make it challenging for new businesses to establish themselves in the industry. Additionally, producing new biotechnology products can be expensive, particularly when it comes to industries like the production of new medicines. This might be a barrier to entrance for startups or small firms with limited resources.
Report Coverage
Global Biotechnology research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Biotechnology report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Biotechnology competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Biotechnology market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Biotechnology market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Biotechnology market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Daiichi Sankyo Co Ltd., Otsuka Holdings, Amino Up Co., Ltd, KOTAI Biotechnologies, Inc., Chiome Bioscience Inc, Japan Bioinformatics, TOKAI HIT, Artham Therapeutics, inc
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Biotechnology market based on the below-mentioned segments:
Global Biotechnology market, By Application
Global Biotechnology market, Regional Analysis
The market for biotechnology, which was estimated to be worth USD 44.1 billion in 2021, is anticipated to expand at a CAGR OF 6.7% from 2022 to 2030. Japan, one of the world's biggest biotechnology marketplaces, gives research and development a high emphasis. Through a number of programmes, including tax exemptions and funding for R&D, the Japanese government has actively promoted the expansion of the biotechnology sector. The nation's sophisticated healthcare system and the increased need for better drugs brought on by the high proportion of senior residents there further support the growth of the biotechnology sector globally.
This study classifies the Japan Biotechnology Market into a number of regions and market segments, projects revenue growth, and examines trends in each submarket. The main growth factors, opportunities, and difficulties affecting the Japan Biotechnology Market are analysed in the report. The competitive landscape in the market has been depicted by including recent market developments and competitive tactics including growth, product launch and development, partnerships, mergers, and acquisitions. The key market players are strategically identified, profiled, and their core competencies in each of the Japan Biotechnology Market's sub-segments are analysed in the study.
Driving Factors
The Japanese biotechnology market is expanding as a result of a number of factors, including the huge geriatric population (25 percent of the country's population is over 65 years old). As a result, there is now a greater need for healthcare services and cutting-edge anti-aging drugs. Recent increases in healthcare spending by the Japanese government have led to more funding for research and development in the biotechnology sector, which is another key factor in Japan's economic expansion. Additionally, the biotechnology industry has benefited from Japan's standing as a leader in technological innovation. The Japanese government has aggressively supported the expansion of the biotechnology sector through a number of initiatives, such as tax breaks and financing for R&D. With regard to research and development, Japan has a stellar track record thanks to superior research capabilities, particularly in industries like pharmaceuticals and medical devices. This has given the biotechnology sector a plethora of information and experience. Throughout the projection period, it is anticipated that these driving forces will continue to support the expansion of the Japanese biotechnology market.
Restraining Factors
The Japan Biotechnology Market is experiencing growth restraints as a result of regulatory issues. The biotechnology sector in Japan is highly regulated, which can make it challenging for businesses to launch new products. The regulatory process can be prohibitively expensive and time-consuming for smaller enterprises. Additionally, there are numerous well-established players in the market, which makes it quite competitive. This may make it challenging for new businesses to establish themselves in the industry. Additionally, producing new biotechnology products can be expensive, particularly when it comes to industries like the production of new medicines. This might be a barrier to entrance for startups or small firms with limited resources.
Report Coverage
Global Biotechnology research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Biotechnology report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Biotechnology competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Biotechnology market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2020 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2019 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Daiichi Sankyo Co Ltd., Otsuka Holdings, Amino Up Co., Ltd, KOTAI Biotechnologies, Inc., Chiome Bioscience Inc, Japan Bioinformatics, TOKAI HIT, Artham Therapeutics, inc |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Biotechnology Market from 2021 to 2030.
- Market Forecast for Biotechnology Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Biotechnology competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Biotechnology
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Biotechnology market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Biotechnology market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Takeda Pharmaceutical Co Ltd, Astellas Pharma Inc, Daiichi Sankyo Co Ltd., Otsuka Holdings, Amino Up Co., Ltd, KOTAI Biotechnologies, Inc., Chiome Bioscience Inc, Japan Bioinformatics, TOKAI HIT, Artham Therapeutics, inc
Primary Target Market
- Market Players of Biotechnology
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. Spherical Insights has segmented the global Biotechnology market based on the below-mentioned segments:
Global Biotechnology market, By Application
- Bio-pharmacy
- Bio-industries
- Bio-services
- Bio-agriculture
- Bioinformatics
Global Biotechnology market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive biotechnology market market research and competitor analysis for your business to help you develop more profound insights into the biotechnology market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the biotechnology market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.